Live symbol workspace

LLY market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $935.58

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$888.80

Resistance

$982.36

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$935.58

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 11 calls in the last 7 days

What sources say

Bullish 1 article

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Neutral 1 article

Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq

Insider Trading

Insider	Role	Date	Type	Value
Jonsson Patrik	EVP & …	Aug 17 '26	Sale	7638150.0
Patrik Jonsson	Officer	Aug 17 '26	Proposed Sale	7638150.0
Zakrowski Donald A	SVP, Finance, …	Aug 10 '26	Sale	2370020.0
DONALD ZAKROWSKI	Officer	Aug 10 '26	Proposed Sale	2371420.0
Hakim Anat	EVP, GC …	Aug 07 '26	Sale	5950000.0
Hakim Anat	Officer	Aug 07 '26	Proposed Sale	11900000.0
Seymour Melissa	EVP, Global …	Aug 01 '26	Option Exercise	0.0
LILLY ENDOWMENT, INC.	Shareholder	Jul 07 '26	Proposed Sale	372018600.0
LILLY ENDOWMENT, INC.	Shareholder	Jun 26 '26	Proposed Sale	343945450.0
Yuffa Ilya	EVP&Pres, LLY …	Jun 10 '26	Sale	2876925.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

LLY News Intelligence (27 articles)

AI-curated news influencing LLY price, sentiment, and trend

Explore All LLY News with AI Analysis

Global Markets & Finance

4 months, 4 weeks ago

Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech

Global pharmaceutical companies are aggressively searching for new medicines in China

Impact on LLY: The deal is likely to have a positive impact on Eli Lilly's …

Eli Lilly is set to sign a $2 billion deal with a Hong Kong biotech … High (80%)

View full analysis →

Financial Times 80% confidence

Stocks

5 months, 1 week ago

An end to the Iran conflict should rally stocks — but only briefly

Private-credit cracks, high stock valuations and shaky IPO prospects will curb investors’ enthusiasm.

Impact on LLY: Neutral market sentiment indicated

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)

View full analysis →

MarketWatch 94% confidence

Economy

5 months, 1 week ago

Lilly Gets Lone Sell From HSBC Ahead of Deeper Weight Loss Drug Price Cuts

Eli Lilly & Co. shares dip after HSBC turned bearish on the stock, for the second time in a year, …

Impact on LLY: The bearish call from HSBC may lead to a short-term decline in …

Eli Lilly & Co. shares experience a decline after HSBC turns bearish on the stock, … High (70%)

View full analysis →

Bloomberg 70% confidence

Economy

5 months, 2 weeks ago

Should You Buy Eli Lilly Stock Now or Wait for More of a Pullback?

Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.

Impact on LLY: Market impact analysis based on bearish sentiment with 80% confidence.

Eli Lilly's stock is considered overpriced, despite a decline this year, making it a potentially … High (80%)

View full analysis →

Yahoo Finance 80% confidence

Economy

6 months ago

Is Eli Lilly Stock Underperforming the S&P 500?

Eli Lilly has recently trailed the S&P 500 Index, though analysts remain confident in its longer-term trajectory.

Impact on LLY: Market impact analysis based on neutral sentiment with 70% confidence.

Eli Lilly stock has underperformed the S&P 500 Index, but analysts remain optimistic about its … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

6 months, 2 weeks ago

Eli Lilly Stock Rises. It’s Acquiring This Cell Therapy Company for $2.4 Billion.

Eli Lilly shares rose after the Mounjaro maker said it had agreed to acquire biotechnology company Orna Therapeutics for $2.4 …

Impact on LLY: Market impact analysis based on bullish sentiment with 90% confidence.

Eli Lilly's stock rose after the company announced a $2.4 billion acquisition of Orna Therapeutics, … High (90%)

View full analysis →

Yahoo Finance 90% confidence